| Application no. and date | 04757724.2 (espacenet) (Federated) (European Patent Register), 20040317 | | Patent/reg. no. and date | DK/EP 1608349, 20071017 | | Publication date | 20051228 | | Priority no. and date | US 391196, 20030319 | | EP pub. no. and date |
EP 1608349 20051228 | | Effective date | | | Applicant/owner | Dexcel Pharma Technologies Ltd., P.O. Box 23950
91237 Jerusalem, IL | | Applicant ref. no. | 84814 | | Inventor | PENHASI, Adel, 53/15 Rabinovitch Street
Holon 58671, IL,
REUVENI, Albert, 503/51 Shevo Street
Jerusalem 93845, IL,
OREN, Dan, 48 Hazorea Street
Kfar Shmariahu 46910, IL | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 31/19 (2006.01) , A61K 9/70 (2006.01) , A61P 29/00 (2006.01) | | Title | Oralt tilførselssystem omfattende et antibakterielt og et antiinflammatorisk middel | | Int. application no. | IL2004000252 | | Int. publication no. | WO2004084873 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
